Analyst Perseus Perspectives argues that the recent sell-off of IBM’s stock, attributed to fears surrounding Anthropic’s new AI tool Claude Cowork, is exaggerated. IBM’s established software, which integrates deeply into mission-critical applications for major enterprises like banks, is not at risk of being easily replaced by AI advancements, especially given that IBM’s Watsonx platform already automates the refactoring of COBOL code. Despite a broader market trend of selling off software stocks amid AI hype, IBM’s financial health remains robust, bolstered by its $14.7 billion in free cash flow and historical reliability as a trusted partner for long-term clients.
Analyst maintains buy rating on IBM amid overblown AI sell-off
